Maartje M. Van Den Belt
Wageningen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of 3-day turmeric supplementation on fasting and postprandial LPS and chylomicron-related markers in patients with IBS: A randomized crossover trial.
Journal: The British journal of nutrition
Published: August 03, 2026
Randomised controlled trial: nutritional supplements to relieve irritable bowel syndrome symptoms by targeting the gut microbiota.
Journal: Journal of nutritional science
Published: November 21, 2024
A double-blind intervention trial in healthy women demonstrates the beneficial impact on Bifidobacterium with low dosages of prebiotic galacto-oligosaccharides.
Journal: Frontiers in nutrition
Published: May 29, 2024
Rationale and design of a randomized placebo-controlled nutritional trial embracing a citizen science approach.
Journal: Nutrition research (New York, N.Y.)
Published: February 14, 2024
Are postprandial glucose responses sufficiently person-specific to use in personalized dietary advice? Design of the RepEAT study: a fully controlled dietary intervention to determine the variation in glucose responses.
Journal: Frontiers in nutrition
Published: August 23, 2023
Changes in gut microbiota and lactose intolerance symptoms before and after daily lactose supplementation in individuals with the lactase nonpersistent genotype.
Journal: The American journal of clinical nutrition
Published: July 12, 2023
Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
Journal: The Lancet. Child & adolescent health
Published: April 21, 2022
A Double-Blind, Randomized Intervention Study on the Effect of a Whey Protein Concentrate on E. coli-Induced Diarrhea in a Human Infection Model.
Journal: Nutrients
Published: January 13, 2022
Low doses of diarrhoeagenic E. coli induce enhanced monocyte and mDC responses and prevent development of symptoms after homologous rechallenge.
Journal: PloS one
Published: January 08, 2022
Last Updated: 09/26/2026